$2.52
+0.20 (+8.62%)
Open$2.35
Previous Close$2.32
Day High$2.68
Day Low$2.35
52W High$35.44
52W Low$27.88
Volume—
Avg Volume67.9K
Market Cap97.26M
P/E Ratio28.72
EPS$1.14
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+1,244.8% upside
Current
$2.52
$2.52
Target
$33.89
$33.89
$29.33
$33.89 avg
$54.04
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 14.50M | 14.53M | 15.74M |
| Net Income | -1,413,235 | -1,603,701 | -1,555,725 |
| Profit Margin | -9.8% | -11.0% | -9.9% |
| EBITDA | -1,727,030 | -1,702,906 | -1,797,734 |
| Free Cash Flow | -928,870 | -884,905 | -1,153,129 |
| Rev Growth | -0.7% | +22.5% | +19.6% |
| Debt/Equity | 0.72 | 0.67 | 0.72 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |